ConductScience.org, home

Trial · NCT07493161

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryRate of BCR::ABL1 ≤0.01% at 90 days (after three cycles of treatment)up to 90 days
PrimaryModified Event-Free Survival (mEFS) from start of InO consolidationFrom the start of InO consolidation therapy up to 2 years
SecondaryOverall Survivalup to 5 years
SecondaryRelapse-Free Survivalup to 5 years
SecondaryCumulative incidence of molecular relapseup to 5 years
SecondaryCumulative incidence of hematologic relapseup to 5 years
SecondaryProportion of patients with next-generation sequencing minimal residual disease <0.01% after three cycles of treatment (90 days)up to 90 days
SecondaryProportion of patients with next-generation sequencing minimal residual disease <0.01% at the end of consolidation therapyup to 1 year
SecondaryIncidence of treatment-related cardiovascular eventsup to 5 years from the initiation of treatment
SecondaryProportion of patients with BCR::ABL1 ≤0.01% at completion of consolidation therapyup to 9 months
SecondaryIncidence of SOS/VODFrom the start of InO consolidation therapy up to 6 months post-treatment
SecondaryHematopoietic Stem Cell Transplantation (HSCT) rateup to 5 years

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07493161/registered